I am a Visiting Scientist in the Garvan Institute of Medical Research where my research centres on the molecular evolution of human cancers, and a Conjoint Professor of the UNSW Clinical School, St Vincent's Hospital.
In my clinical work, since 2018 I have been the Medical Director and Department Chair of Oncology, New Hope Cancer Centre, Beijing United Hospital, China. We have a close working relationship with Peking University Cancer Hospital, and are GCP-accredited for recruiting patient to clinical trials.
Before returning in 2009 to Sydney, where I helped to set up The Kinghorn Cancer Centre, I had helped to set up major new Cancer Centres in Singapore and The University of Hong Kong.
In 1996 I patented the invention of phosphorylation-state-specific antibodies, which invention has since earned approximately US$20m royalties for Harvard University and Dana-Farber Cancer Institute, and led to development of a number of successful diagnostic reagent companies.
1985-88 Sir Robert Menzies Memorial Scholarship in Medicine, to Cambridge University
1988-93 Lucille P. Markey Visiting Fellowship in Biomedical Research, to Harvard University
1993-98 Cancer Research Campaign Senior Clinical Fellowship, to Imperial College London
2003 Richard Asher Prize, Royal Society of Medicine
Over my career I have been awarded approximately A$10m in grants and research support. These grants included two single-applicant NIH grants, one R29 and one R01.